Robert Philibert
Direttore Tecnico/Scientifico/R&S presso CARDIO DIAGNOSTICS HOLDINGS, INC.
Patrimonio netto: 1 M $ in data 30/04/2024
Profilo
Robert Philibert is the founder of Behavioral Diagnostics, LLC (founded in 2009) and Cardio Diagnostics, Inc. (founded in 2017).
He is currently the Chief Medical Officer & Director at Cardio Diagnostics Holdings, Inc. (since 2022) and a Professor at the University of Iowa (since 1998).
He completed his undergraduate degree at the University of Iowa.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/04/2024 | 1 649 792 ( 7.64% ) | 1 M $ | 30/04/2024 |
Posizioni attive di Robert Philibert
Società | Posizione | Inizio |
---|---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 25/10/2022 |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Fondatore | 01/05/2017 |
University of Iowa | Corporate Officer/Principal | 01/01/1998 |
Precedenti posizioni note di Robert Philibert
Società | Posizione | Fine |
---|---|---|
Behavioral Diagnostics, LLC | Fondatore | - |
Formazione di Robert Philibert
University of Iowa | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
Behavioral Diagnostics, LLC |
- Borsa valori
- Insiders
- Robert Philibert